GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » L&K Biomed Co Ltd (XKRX:156100) » Definitions » Change In Receivables

L&K Biomed Co (XKRX:156100) Change In Receivables : ₩-3,247 Mil (TTM As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is L&K Biomed Co Change In Receivables?

L&K Biomed Co's change in receivables for the quarter that ended in Mar. 2024 was ₩-2,762 Mil. It means L&K Biomed Co's Accounts Receivable increased by ₩2,762 Mil from Dec. 2023 to Mar. 2024 .

L&K Biomed Co's change in receivables for the fiscal year that ended in Dec. 2023 was ₩-2,093 Mil. It means L&K Biomed Co's Accounts Receivable increased by ₩2,093 Mil from Dec. 2022 to Dec. 2023 .

L&K Biomed Co's Accounts Receivable for the quarter that ended in Mar. 2024 was ₩12,316 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. L&K Biomed Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 123.14.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. L&K Biomed Co's liquidation value for the three months ended in Mar. 2024 was ₩-1,555 Mil.


L&K Biomed Co Change In Receivables Historical Data

The historical data trend for L&K Biomed Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

L&K Biomed Co Change In Receivables Chart

L&K Biomed Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,082.69 6,999.46 50.06 -522.25 -2,093.29

L&K Biomed Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,608.03 -898.11 2,218.75 -1,805.90 -2,762.13

L&K Biomed Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-3,247 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


L&K Biomed Co  (XKRX:156100) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

L&K Biomed Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=12315.855/9126.02*91
=123.14

2. In Ben Graham's calculation of liquidation value, L&K Biomed Co's accounts receivable are only considered to be worth 75% of book value:

L&K Biomed Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=6600.265-28014.003+0.75 * 12315.855+0.5 * 21243.822
=-1,555

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


L&K Biomed Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of L&K Biomed Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


L&K Biomed Co (XKRX:156100) Business Description

Traded in Other Exchanges
N/A
Address
17 Floor, 159-1, Mokdongseo-ro, Yangcheon-gu, Seoul, KOR
L&K Biomed Co Ltd is a medical device manufacturer. The company develops, manufactures and markets orthopedic spinal implant of medical devices. Its products are Anterior Cervical plate, Posterior cervical fixation, and Anteiro cervical cage system.

L&K Biomed Co (XKRX:156100) Headlines

No Headlines